294 related articles for article (PubMed ID: 6363278)
1. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
Isakov N; Segal S
Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
[TBL] [Abstract][Full Text] [Related]
2. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
3. Thyroid graft rejection between C57BL/6 and H-2Kb mutant mice. Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants.
Isakov N; Bach FH
Transplantation; 1983 Nov; 36(5):571-7. PubMed ID: 6356521
[TBL] [Abstract][Full Text] [Related]
4. Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.
Azuma T; Sato S; Kitagawa S; Hori S; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Jul; 143(1):1-8. PubMed ID: 2525143
[TBL] [Abstract][Full Text] [Related]
5. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
[TBL] [Abstract][Full Text] [Related]
7. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
8. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
Isakov N; Bach FH
J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
[TBL] [Abstract][Full Text] [Related]
9. Requirement of the thymus for the recovery of anti-alloantigen helper T cells from tolerance induced by intravenous presensitization with allogeneic cells.
Kitagawa S; Sato S; Azuma T; Hori S; Hamaoka T; Fujiwara H
J Immunol; 1990 Jun; 144(11):4139-46. PubMed ID: 2140387
[TBL] [Abstract][Full Text] [Related]
10. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
[TBL] [Abstract][Full Text] [Related]
11. [In vivo activity of cytotoxic lymphocytes directed against the product of gene H-2Kb and its mutant alleles].
Nikonenko BV; Pospelov LE
Biull Eksp Biol Med; 1981 Apr; 91(4):479-80. PubMed ID: 7020792
[TBL] [Abstract][Full Text] [Related]
12. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
[TBL] [Abstract][Full Text] [Related]
13. H-2K region-controlled products of the murine major histocompatibility complex differ in their immunogenic capacity when expressed on different tissues.
Isakov N; Feldman M; Segal S
Transplantation; 1981 Oct; 32(4):291-5. PubMed ID: 6173938
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
[TBL] [Abstract][Full Text] [Related]
15. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
16. Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes.
Wettstein PJ; Colombo MP; Jaenisch R
J Immunol; 1988 Jun; 140(12):4337-41. PubMed ID: 3286772
[TBL] [Abstract][Full Text] [Related]
17. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
Rolink AG; Pals ST; Gleichmann E
J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
[TBL] [Abstract][Full Text] [Related]
18. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
19. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
